Presentation: Why Outsource Clinical Trials ...in Emerging Markets ?

Email address:

First name:

Last name:

Job title:

Company name:

Country:

I work for

Please specify your industry *

please check before submitting

Mobile number:

What is your role?

Subscribe to VaccineNation Newsletter?

Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Remember my details

We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

close »

Why Outsource Clinical Trials ...in Emerging Markets ?
General reasons: less investment, specific expertise, company strategy, etc.
But what about emerging markets: Less costly, Faster recruitment, better retention, Research –naïve population, Specific populations, Universal regulations (ICH-GCP)

Optimising clinical trial outsourcing partnerships in emerging markets

· Building mutually beneficial relationships between vaccine manufacturers and CROs

· Support structures for Pharma/Biotech companies from clinical trials to market supply – what are the best practice benchmarks?

· How Pharma/Biotech can increase collaborative efforts with CROs to increase efficiency

Dr Eduardo Motti, Regional Head of Clinical Operations, Latin America, Pfizer

Presentation: Why Outsource Clinical Trials ...in Emerging Markets ?

information we require

please check before submitting